Lipid-regulating drugs

Embedding pharmacist-led lipid optimisation clinics in cardiac rehabilitation

Cardiology pharmacist Niharika Duggal shares how her integrated care system launched a pilot project in Coventry and Warwickshire to tackle the gap in cardiovascular disease care.…

Tips for effective lipid management consultations for secondary prevention of cardiovascular disease

Practical advice for pharmacy teams on how to provide long-term support for patients, improve adherence and achieve target lipid-levels.…

Health news round-up: cardiovascular research special

Senior clinical reporter Joanna Robertson summarises some important developments in health news.…

Health news round-up: AI, health inequalities and GLP-1 drugs

Senior clinical reporter Joanna Robertson shares some important developments in health news.…

Statin prescribing in England at record high, show NICE data

Figures show that atorvastatin prescribing increased from 4.2 million people in 2022/2023 to 5.0 million people in 2023/2024.…

Lipid-lowering therapies for the secondary prevention of cardiovascular disease in primary care

An overview of how updated guidance relating to the secondary prevention of cardiovascular disease can be applied in practice, considering the availability of newer medications.…

Statins offer cost-effective benefit for older people, study results suggest

The researchers found that lifetime use of a standard statin therapy increased quality-adjusted life years by 0.24–0.70 per person.…

Statin alternative may be as effective in cutting risk of heart attack and stroke, shows research

Researchers say it was not known until now that bempedoic acid offered cardiovascular benefit, as well as lowering LDL-C.…

Should all adults be considered for statin therapy?

A closer look at the arguments for and against the latest changes to National Institute for Health and Care Excellence guidelines for statin therapy.…

Statins ‘rarely’ cause muscle pain in patients, find researchers

Results of a study looking at whether statins cause muscle problems showed only a 3% increased relative risk of muscle problems in people taking statins compared with placebo.…